Structural Bioinformatics of Human HMG-CoA Reductase Inhibition by Statins

Abstract

Familial Hypercholesterolemia (FH) is a hereditary disorder characterized by elevated levels of low-density lipoprotein cholesterol (LDL-C), predisposing affected individuals to premature cardiovascular disease. The HMGCR gene, encoding 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMG Co A reductase), plays a crucial role in cholesterol metabolism and is frequently implicated in FH pathogenesis. Here, we carried out an in-silico characterization of human HMG-CoA reductase using structural bioinformatics resources to elucidate the spectrum of enzyme-inhibitor interactions. By examining the 3D profiles of the substrate binding pocket of HMG-CoA reductase, insights into the structural implications of statin inhibition were gained.